Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Efficacy of AXERT (Almotriptan Malate) in the Acute Treatment of Migraine: A Pilot Study of the Potential Impact of Preventive Therapy With TOPAMAX (Topiramate)

NCT00210496 is registered in ClinicalTrials.gov with Janssen-Ortho LLC as lead sponsor.

NCT NCT00210496
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00210496 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Efficacy of AXERT (Almotriptan Malate) in the Acute Treatment of Migraine: A Pilot Study of the Potential Impact of Preventive Therapy With TOPAMAX (Topiramate)
Lead sponsor
Janssen-Ortho LLC
Phase
Phase 4
Overall status
Completed
Start date
June 30, 2005
Completion date
June 30, 2007
Enrollment
406 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

classic migraine, common migraine, migraine